Skip to main content
Equibles

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in LNSR — LENSAR, Inc.

CIK 861177 NEW YORK, NY
Back to LNSR Full portfolio

Position in LNSR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,576
-$375 QoQ
Shares Held
1,502
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 74 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LNSR Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,748,157,927 across 62 Medical Devices names. LNSR ranks #50 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABT
Abbott Laboratories
 12,835,753 $1,164,716,222
2 SYK
Stryker Corp
 2,689,376 $846,723,135
3 DXCM
Dexcom Inc
 11,261,876 $758,487,343
4 BSX
Boston Scientific Corp
 13,091,481 $558,744,402
5 EW
Edwards Lifesciences Corp
 5,488,643 $496,502,640
6 GEHC
GE HealthCare Technologies Inc.
 2,541,393 $162,674,562
7 ZBH
Zimmer Biomet Holdings, Inc.
 1,457,553 $125,480,733
8 BIO
Bio-Rad Laboratories, Inc.
 418,884 $122,988,525

All Filings in LNSR

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,576 1,502
2026-03-31 $8,951 1,502